Collegium Pharma (COLL): Emerging Leader in Opioid Pain Management - HC Wainwright
H.C. Wainwright analyst, Ed Arce, reiterated his Buy rating on shares of Collegium Pharmaceutical (NASDAQ: COLL) and raised his price ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)